Ziel
Diabetic retinopathy (DR), the leading cause of blindness among working-age individuals in developed countries has been classically considered to be a microcirculatory disease of the retina. However, there is growing evidence to suggest that retinal neurodegeneration is an early event in the pathogenesis of DR. For this reason, it is reasonable to hypothesize that therapeutic strategies based on neuroprotection will be effective not only in preventing or arresting retinal neurodegeneration but also in preventing the development and progression of the early stages of DR (ie. microaneurysms and/or retinal thickness).
EUROCONDOR (European Consortium for the Early Treatment of Diabetic Retinopathy) is a solid and well balanced consortium (ophthalmologists, endocrinologists, basic researchers) which has been created in order to implement the first clinical trial using eye drops for treatment of the early stages of DR. The participants are top leaders in their field and central readings will be performed by the Coordinating Centre of the European Vision Institute Clinical Research Network (EVICR.Net).
The main objectives of the project are the following:
Primary objective: To assess whether the selected neuroprotective drugs (brimonidine and somatostatin) administered topically are able to prevent or arrest neurodegeneration, as well as the development and progression of the early stages of DR.
Secondary objectives: 1) To determine the prevalence of functional abnormalities related to neurodegeneration in those patients without or with minimal microvascular damage under ophthalmoscopic examination. 2) To compare the effectiveness of the selected drugs. 3) To evaluate the local and systemic adverse effects of the selected drugs. 4) To identify those patients most prone to progressive worsening (characterization of phenotypes and circulating biomarkers). 5) To determine the molecular mechanisms by which the selected drugs exert their beneficial effects.
Wissenschaftliches Gebiet
Programm/Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
FP7-HEALTH-2011-two-stage
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
CP-FP - Small or medium-scale focused research projectKoordinator
08035 Barcelona
Spanien
Auf der Karte ansehen
Beteiligte (17)
3000 548 Coimbra
Auf der Karte ansehen
5230 Odense M
Auf der Karte ansehen
89081 Ulm
Auf der Karte ansehen
20132 Milano
Auf der Karte ansehen
35122 Padova
Auf der Karte ansehen
GL53 7AN CHELTENHAM
Auf der Karte ansehen
08007 Barcelona
Auf der Karte ansehen
EC1V 2PD London
Auf der Karte ansehen
75012 Paris
Auf der Karte ansehen
L69 7ZX Liverpool
Auf der Karte ansehen
B4 7ET Birmingham
Auf der Karte ansehen
10124 Torino
Auf der Karte ansehen
46012 Valencia
Auf der Karte ansehen
28006 Madrid
Auf der Karte ansehen
1090 Bruxelles / Brussel
Auf der Karte ansehen
08777 SANTA QUINTI DE MEDIONA
Auf der Karte ansehen
Beteiligung beendet
28029 MADRID
Auf der Karte ansehen